Registry of outcomes for patients with advanced thyroid cancer
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
This study looks at how well different treatments work for people with advanced thyroid cancer, comparing those treated at MD Anderson Cancer Center to those treated elsewhere, while also checking how these treatments affect their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 459 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06507878 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather real-world data on patients with advanced thyroid cancer, focusing on their access to treatments and how they respond to commercially available medications outside of clinical trials. The primary objective is to compare overall survival between patients treated at MD Anderson Cancer Center and those treated elsewhere, based on their BRAF status and disease stage. Additionally, the study will evaluate the impact of various therapies on the quality of life of survivors and how sociodemographic factors influence patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adult patients aged 18 years or older diagnosed with anaplastic thyroid cancer or poorly differentiated thyroid cancer.
Not a fit: Patients without a diagnosis of anaplastic or poorly differentiated thyroid cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of treatment access and effectiveness for advanced thyroid cancer, leading to better patient outcomes.
How similar studies have performed: Other studies have shown success in gathering real-world data for cancer treatments, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All adult patients aged 18 years or older (with the exception of certain external participant countries where the legal adult age may be different; for example in Singapore, adult majors are defined by age 21 and older) with anaplastic thyroid cancer or poorly differentiated thyroid cancer as their clinical and/ or histological diagnosis will be included. Exclusion Criteria: Patients who do not have anaplastic thyroid cancer or poorly differentiated thyroid cancer on their tumor tissue would be excluded.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Priyanka C Iyer, MBBS — M.D. Anderson Cancer Center
- Study coordinator: Priyanka C Iyer, MBBS
- Email: piyer@mdanderson.org
- Phone: (832) 291-6069
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.